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Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) not only holds great promise to model and treat many diseases but can also provide insights into aging and rejuvenation mechanisms (Studer et al., 2015) . Indeed, reprogramming of aged somatic cells into iPSCs reverts some hallmarks of agingincluding telomere length, mitochondrial fitness, abnormal nuclear morphologies, loss of heterochromatin markers, and gene expression-to a youthful embryonic state (Studer et al., 2015) . In this issue of Cell, Ocampo et al. (2016) apply stem cell reprogramming factors in vivo to improve the health of an organism and to prolong its lifespan. They first find that transient in vitro expression of the four Yamanaka reprogramming factors-Oct4, Sox2, Klf4, and c-Myc (OSKM)-reverts age-associated features in mouse and human cells, without the loss of cellular identity. Remarkably, the authors show that at the organism level, short-term induction of the four reprogramming factors improves the physical state of a mouse model of premature aging and extends its lifespan. Importantly, they also provide evidence that transient expression of the four factors has beneficial effects in physiologically aged, normal mice.
An intriguing yet unexplored question in the aging and reprogramming field has been whether it is possible to uncouple the rejuvenation and the dedifferentiation process associated with iPSC reprogramming. Although previous studies have shown that transient expression of the four factors can induce a partially dedifferentiated state (without a complete loss of cellular identity) (Kurian et al., 2013), whether this partial state is sufficient to revert age-associated features remained unclear. The authors now show that short-term expression of the four Yamanaka factors is sufficient to revert some age-associated features in mouse and human cells without dedifferentiation. Using fibroblasts from a transgenic mouse model of premature aging (a model for Hutchinson Gilford Progeria Syndrome) that also carries an inducible OSKM polycistronic cassette, they show that short-term induction of OSKM (2 to 4 days) reduces markers of DNA damage (gH2AX), senescence, and mitochondrial impairment (reactive oxygen species production), without the loss of cellular identity. Moreover, expression of reprogramming factors restores the levels of two epigenetic marks of heterochromatin that have previously been associated with aging and progeria, namely trimethylated lysine 9 on histone H3 (H3K9me3) and H4K20me3 (Pal and Tyler, 2016) . These effects are not observed upon induction of a single reprogramming factor, suggesting that a combination of the four factors is required. Interestingly, 8 days after OSKM induction, the progeria-associated features slowly come back, suggesting that OSKM expression provides a transient reversion of premature aging phenotypes. However, the re-establishment of age-associated features may be specific to the progeria model used, whose cells carry a genetic alteration. Additional experiments will be required to examine how well these findings recapitulate in cells from normal old mice.
What drives the reversion of these ageassociated features? Ocampo et al. (2016) provide evidence that epigenetic changes may be at the core of this reversion. In time-course experiments, the epigenetic changes precede the reversion of DNA damage and senescence markers, and chemical inhibition of H3K9me3 methyltransferases abrogates the rejuvenation effect. However, many questions remain; for example, it is unclear which precise histone mark is required. The authors show restored levels of H3K9me3 and H4K20me3, but the reprogramming factors induce a complete remodeling of the chromatin landscape (Takahashi and Yamanaka, 2016) . Are alterations of other histone marks (e.g., H3K4me3 and H3K27me3, which also change which age) required, and to what extent? Interestingly, H3K9me3 marks mainly constitutive heterochromatin and is often found coating retrotransposal elements, thereby preventing their spurious reactivation. Expression of retrotransposal elements has been associated with cellular senescence and organismal aging, and suppression of these elements can reverse the senescence phenotype, at least in vitro (Pal and Tyler, 2016) . These findings suggest a critical role of epigenetic remodeling in the rejuvenation process, perhaps by improving genomic stability. These results raise the exciting possibility that epigenetic changes supersede/precede other aging hallmarks in the physiological aging process, as well, and may thus constitute a key target for future rejuvenation strategies. It would be interesting to determine if transient pulses of OSKM are sufficient to erase other hallmarks of aging-including metabolism defects, increased inflammation, and increased protein aggregates-and determine their hierarchy compared to epigenetic events in this process.
